Clinical trial
Study Of Adults And Adolescents With Vasomotor Rhinitis
NCT00117325 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00117325 |
|---|---|
| Title | Study Of Adults And Adolescents With Vasomotor Rhinitis |
| Official title | A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rhinitis, Vasomotor |
| Intervention type | Drug |
| Interventions | GW685698X |
| Enrollment | 352 |
| Start date | Jul 11, 2005 |
| Primary completion | Feb 9, 2006 |
| Completion | Feb 9, 2006 |
| First posted | Jul 6, 2005 |
| Last update posted | Mar 13, 2018 |
| Countries | Canada, Czechia, Germany, Norway, Romania, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: